Bemnifosbuvir
id:
bemnifosbuvir-197-3399801
title:
Bemnifosbuvir
text:
Bemnifosbuvir is an antiviral drug invented by Atea Pharmaceuticals and licensed to Roche for clinical development, a novel nucleotide analog prodrug originally developed for the treatment of hepatitis C. Bemnifosbuvir is the orally bioavailable hemisulfate salt of AT-511, which is metabolized in several steps to the active nucleotide triphosphate AT-9010, acting as an RNA polymerase inhibitor and thereby interfering with viral replication. Bemnifosbuvir has been researched for the treatment of
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Bemnifosbuvir
date created:
date modified:
2024-02-18T02:31:28Z
main entity:
{"identifier":"Q107209409","url":"https://www.wikidata.org/entity/Q107209409"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/f/f5/Bemnifosbuvir.svg","width":1054,"height":423}
fields total:
13
integrity:
15